Stock listing
TPEx:6945 AP Biosciences, Inc. (圓祥生技) 股價
Follow AP Biosciences, Inc. into a list and get an email when it puts out news.
Share price · TPEX:6945
$97.20 TWD -22.80 (-19.0%)
Close on Nov 20, 2026
- Day range
- $97.20 – $102.50 TWDNov 20, 2026
- Volume
- 379,351 sharesNov 20, 2026
- Market cap
- $9.30B TWDAt the close on Nov 20, 2026 · price × 95.70M shares outstanding
- Traded on an average day
- $45.18M TWDMedian day 274,124 shares · 1 day with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TPEX:6945 · TWD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $97.20 | -22.80 | -19.0% | $101.00 | $102.50 | $97.20 | 379,351 | |
| $120.00 | -3.00 | -2.4% | $127.00 | $127.00 | $117.50 | 240,716 | |
| $123.00 | +8.50 | +7.4% | $119.00 | $124.50 | $115.00 | 509,651 | |
| $114.50 | -3.50 | -3.0% | $124.50 | $127.00 | $112.50 | 290,575 | |
| $118.00 | +4.00 | +3.5% | $117.00 | $123.00 | $117.00 | 201,796 | |
| $114.00 | -3.50 | -3.0% | $118.00 | $119.00 | $114.00 | 165,321 | |
| $117.50 | +2.50 | +2.2% | $115.00 | $118.50 | $112.00 | 157,948 | |
| $115.00 | +3.00 | +2.7% | $115.00 | $117.50 | $112.00 | 138,987 | |
| $112.00 | 0.00 | 0.0% | $115.00 | $117.00 | $110.00 | 160,991 | |
| $112.00 | -4.00 | -3.4% | $104.50 | $118.00 | $104.50 | 320,907 | |
| $116.00 | -7.00 | -5.7% | $124.00 | $127.00 | $116.00 | 421,185 | |
| $123.00 | -6.50 | -5.0% | $131.50 | $131.50 | $122.50 | 361,732 | |
| $129.50 | +2.50 | +2.0% | $127.00 | $132.00 | $123.00 | 368,603 | |
| $127.00 | -6.50 | -4.9% | $132.00 | $133.50 | $127.00 | 261,247 | |
| $133.50 | +0.50 | +0.4% | $132.50 | $134.50 | $128.00 | 335,652 | |
| $133.00 | -0.50 | -0.4% | $131.50 | $134.00 | $129.00 | 196,289 | |
| $133.50 | +1.50 | +1.1% | $133.50 | $134.00 | $127.00 | 288,912 | |
| $132.00 | +3.00 | +2.3% | $128.00 | $134.50 | $125.00 | 408,874 | |
| $129.00 | 0.00 | 0.0% | $129.00 | $129.00 | $129.00 | 0 | |
| $129.00 | +11.50 | +9.8% | $116.50 | $129.00 | $116.50 | 554,102 | |
| $117.50 | -1.00 | -0.8% | $119.50 | $120.50 | $117.00 | 129,203 | |
| $118.50 | +2.00 | +1.7% | $116.50 | $120.00 | $116.50 | 116,551 | |
| $116.50 | -5.50 | -4.5% | $124.50 | $124.50 | $114.00 | 188,300 | |
| $122.00 | 0.00 | 0.0% | $122.50 | $123.50 | $121.00 | 130,001 | |
| $122.00 | -0.50 | -0.4% | $120.50 | $127.50 | $120.00 | 287,000 | |
| $122.50 | -1.00 | -0.8% | $121.50 | $124.00 | $121.00 | 157,100 | |
| $123.50 | -2.00 | -1.6% | $126.00 | $126.00 | $120.00 | 249,000 | |
| $125.50 | -7.50 | -5.6% | $133.50 | $133.50 | $125.50 | 415,265 | |
| $133.00 | -7.00 | -5.0% | $137.00 | $140.50 | $129.50 | 771,549 | |
| $140.00 | -2.00 | -1.4% | $144.00 | $147.50 | $135.00 | 787,141 | |
| $142.00 | +12.50 | +9.7% | $128.50 | $142.00 | $128.50 | 665,253 | |
| $129.50 | -6.50 | -4.8% | $135.00 | $135.00 | $127.00 | 698,203 | |
| $136.00 | -7.00 | -4.9% | $140.50 | $142.00 | $132.00 | 610,507 | |
| $143.00 | -5.50 | -3.7% | $147.50 | $148.00 | $142.50 | 535,345 | |
| $148.50 | +8.50 | +6.1% | $140.00 | $149.00 | $140.00 | 694,484 | |
| $140.00 | +2.00 | +1.4% | $137.50 | $140.00 | $135.00 | 314,643 | |
| $138.00 | +1.00 | +0.7% | $135.50 | $138.00 | $134.50 | 217,181 | |
| $137.00 | +2.00 | +1.5% | $135.00 | $137.50 | $128.00 | 466,229 | |
| $135.00 | 0.00 | 0.0% | $130.50 | $137.50 | $130.50 | 613,833 | |
| $135.00 | +3.00 | +2.3% | $131.00 | $137.00 | $124.50 | 941,000 | |
| $132.00 | +8.00 | +6.5% | $119.50 | $132.00 | $114.00 | 1,190,299 | |
| $124.00 | +4.00 | +3.3% | $119.50 | $130.00 | $118.00 | 1,754,510 | |
| $120.00 | +10.50 | +9.6% | $114.50 | $120.00 | $110.50 | 686,025 | |
| $109.50 | +9.70 | +9.7% | $100.00 | $109.50 | $100.00 | 805,900 | |
| $99.80 | +1.30 | +1.3% | $98.50 | $99.80 | $96.50 | 133,200 | |
| $98.50 | 0.00 | 0.0% | $99.50 | $99.50 | $96.50 | 174,000 | |
| $98.50 | +3.10 | +3.2% | $95.10 | $98.50 | $94.70 | 130,100 | |
| $95.40 | -0.40 | -0.4% | $97.20 | $97.20 | $95.40 | 68,100 | |
| $95.80 | +0.50 | +0.5% | $94.60 | $96.70 | $94.60 | 84,000 | |
| $95.30 | -0.30 | -0.3% | $97.00 | $97.00 | $95.20 | 120,000 | |
| $95.60 | -1.80 | -1.8% | $95.70 | $97.00 | $95.00 | 69,000 | |
| $97.40 | -0.20 | -0.2% | $98.20 | $99.90 | $93.00 | 156,500 | |
| $97.60 | +1.10 | +1.1% | $96.50 | $97.90 | $95.00 | 113,000 | |
| $96.50 | -1.80 | -1.8% | $98.70 | $99.30 | $96.00 | 310,340 | |
| $98.30 | -5.70 | -5.5% | $105.00 | $105.50 | $98.00 | 442,135 | |
| $104.00 | -3.00 | -2.8% | $107.50 | $107.50 | $103.50 | 164,012 | |
| $107.00 | +5.50 | +5.4% | $103.00 | $109.00 | $103.00 | 602,030 | |
| $101.50 | +1.50 | +1.5% | $100.00 | $103.00 | $100.00 | 167,039 | |
| $100.00 | -1.50 | -1.5% | $101.00 | $102.00 | $99.60 | 91,050 | |
| $101.50 | 0.00 | 0.0% | $101.50 | $104.00 | $100.00 | 230,000 | |
| $101.50 | 0.00 | 0.0% | $103.50 | $104.50 | $100.50 | 213,159 | |
| $101.50 | +2.00 | +2.0% | $104.00 | $105.00 | $101.00 | 132,039 |
- Ticker
- TPEx:6945
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- TPEx
- Currency
- TWD
What changed lately
Latest news release · May 11, 2026
Delos Capital and AP Biosciences Inc. Launch Collaboration to Create New Biotech Companies Focused on Next-Generation Antibodies
Latest news
Delos Capital and AP Biosciences Inc. Launch Collaboration to Create New Biotech Companies Focused on Next-Generation Antibodies
May 11, 2026
Closed $172.50 (+0.3%) on May 11, 2026
AP Biosciences and Tasly Finalize Amended Collaboration Agreement to Support Global Out-Licensing of AP505 (B1962)
Mar 30, 2026
Closed $198.00 (+1.0%) on Mar 31, 2026
AP Biosciences, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 2 in the last 12 months · 2 in all · newest May 11, 2026 · oldest 2026
Valuation
Price/book 4.0× against a median of 1.6×: 6th lowest of 8 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- $7.11B TWD
- P/E
- Loss
- EV/sales
- No revenue
- EV/EBITDA
- Negative EBITDA
- Price/book
- 4.0×
- Gross margin
- No revenue
- Operating margin
- No revenue
- Net margin
- No revenue
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| AP Biosciences, Inc. · TPEX:6945 | US$282.2M | US$215.6M | n/a | n/a | n/a | 4.0× | n/a | 0.0× | n/a |
| Contineum Therapeutics, Inc. · NASDAQ:CTNM | US$286.1M | US$47.86M | n/a | n/a | n/a | 1.2× | n/a | 0.0× | 1.53 |
| TRex Bio, Inc. · NASDAQ:TRXB | US$283.1M | US$205.0M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Greenwich LifeSciences, Inc. · NASDAQ:GLSI | US$282.6M | US$276.7M | n/a | n/a | n/a | n/a | n/a | n/a | 2.80 |
| Precision BioSciences, Inc. · NASDAQ:DTIL | US$282.5M | US$228.3M | n/a | 5.1× | n/a | 5.5× | −85.6% | 0.5× | 0.30 |
| Fulcrum Therapeutics, Inc. · NASDAQ:FULC | US$281.8M | −US$17.87M | n/a | n/a | n/a | 0.9× | n/a | 0.0× | 0.42 |
| Circio Holding ASA · OSL:CRNA | US$281.1M | US$225.9M | n/a | n/a | n/a | 5.3× | n/a | 0.0× | n/a |
| Relmada Therapeutics, Inc. · NASDAQ:RLMD | US$279.5M | US$77.42M | n/a | n/a | n/a | 1.4× | n/a | 0.0× | 1.57 |
| Benitec Biopharma Inc. · NASDAQ:BNTC | US$276.1M | US$99.78M | n/a | n/a | n/a | 1.6× | n/a | 0.0× | 1.46 |
| Vicore Pharma Holding AB · OMXSTO:VICO | US$271.4M | US$182.7M | n/a | 467× | n/a | 3.3× | n/a | 0.0× | n/a |
| Galectin Therapeutics Inc. · NASDAQ:GALT | US$271.4M | US$293.0M | n/a | n/a | n/a | n/a | n/a | n/a | 1.20 |
| Median of the others | US$281.5M | US$193.8M | 236× | 1.6× | −85.6% | 0.0× | 1.46 |
Financials
Annual, in TWD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 32.3M | 0 | 6.99M | 137.6M |
| Cost of revenue | 0 | 17.5M | 0 | 8.68M | 0 | |
| Gross profit | 0 | -17.5M | 32.3M | -8.68M | 6.99M | 137.6K |
| Research and development | 369.8M | 365.4M | 336.6M | 262.7M | 173.8M | 66.8M |
| Selling, general and administrative | 86.6M | 73.1M | 43.1M | 34.8M | 19.9M | |
| Operating income | -456.4M | -439.1M | -347.5M | -288.5M | -186.7M | 45.0M |
| Depreciation and amortization | 25.5M | 17.5M | 12.6M | 8.68M | 8.86M | 7.20K |
| EBITDA | -430.9M | -421.6M | -334.9M | -279.9M | -177.9M | 45.0M |
| Interest expense | 1.42M | 1.65M | 1.20M | 0 | ||
| Income before tax | -444.8M | -422.7M | -339.3M | -288.5M | -187.6M | 41.7M |
| Net income | -444.8M | -422.7M | -339.3M | -288.5M | -187.6M | 41.7K |
| Earnings per share, basic | -5.20 | -5.61 | -5.24 | -5.48 | -3.89 | 0.00 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash and equivalents | 970.9M | 1.44B | 278.6M | 1.05B | 527.1M | 630.7K |
| Short-term investments | 200.0M | 100.0M | 461.4M | 30.7M | 30.0M | |
| Receivables | 4.89M | 2.62M | 1.03M | 17.0K | 105 | |
| Current assets | 1.22B | 1.58B | 765.6M | 1.09B | 563.9M | 632.3K |
| Total assets | 1.37B | 1.73B | 890.8M | 1.10B | 579.3M | 652.0K |
| Current liabilities | 40.8M | 39.7M | 30.9M | 4.52M | 21.1M | 9.16K |
| Total debt | 70.9M | 82.1M | ||||
| Total liabilities | 94.2M | 104.4M | 106.7M | 4.52M | 21.1M | 9.16K |
| Shareholders' equity | 1.27B | 1.62B | 784.1M | 1.10B | 558.2M | 642.9K |
| Shares outstanding | 85.6M | 75.3M | 64.7M | 52.6M | 48.2M | 48.2M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash from operations | -352.1M | -357.9M | -297.6M | -276.0M | -168.7M | -17.0K |
| Capital spending | -25.3M | -5.53M | -35.4M | -2.43M | -4.91M | -7.25K |
| Free cash flow | -377.3M | -363.4M | -333.0M | -278.4M | -173.6M | -24.3K |
| Cash from investing | 326.4M | -468.7M | -3.15M | -34.9M | -7.30K | |
| Cash from financing | 1.20B | -3.10M | 800.0M | 100.0M | 581.1K | |
| Change in cash | -470.8M | 1.16B | -769.4M | 520.9M | -103.6M | 556.8K |
Cap table
Built by 6ix from AP Biosciences, Inc.’s releases
- Common shares
- 95,704,160
- Fully diluted
- 95,704,160
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 95,704,160 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 95,704,160 |
Log in to ask 6ix AI your own questions about AP Biosciences, Inc.